Use of Phospholipase C Zeta Analysis to Identify Candidates for Artificial Oocyte Activation: a Case Series of Clinical Pregnancies and a Proposed Algorithm for Patient Management
Overview
Authors
Affiliations
Objective: To investigate the applicability of phospholipase C zeta (PLCζ) analysis in assisting the clinical decision-making process when considering artificial oocyte activation (AOA) for infertile males in assisted reproductive technology.
Design: Fifty-six males (43 infertile/13 fertile) were screened using our PLCζ assay.
Setting: Fertility unit/university laboratory.
Patient(s): Infertile males with abnormal sperm morphology or total fertilization failure, low fertilization rate (<50%), or repeated fertilization failure in assisted reproductive technology.
Intervention(s): We analyzed PLCζ levels in sperm from fertile and infertile males. Eligible patients subsequently underwent intracytoplasmic sperm injection (ICSI)/artificial oocyte activation (AOA) with calcimycin (GM508).
Main Outcome Measure(s): PLCζ localization and level and the proportion of sperm expressing PLCζ. Thresholds of PLCζ deficiency, fertilization rates, pregnancy rates, and live birth rates of AOA and non-AOA cycles.
Result(s): Compared with 13 fertile controls, 34 of the 43 infertile males had significantly lower levels of PLCζ and/or a significantly lower proportion of sperm exhibiting PLCζ. Of these 34 patients, 15 showed a significant PLCζ reduction in both parameters, which we termed "PLCζ deficiency." Five PLCζ-deficient patients opted for AOA; all five achieved fertilization, and four achieved clinical pregnancies and live births. The fertilization rate improved significantly from 18.6% (ICSI) to 56.8% (ICSI/AOA). The clinical pregnancy rate and live birth rate with AOA were both 40% per initiated cycle. Youden index analysis revealed that the cutoffs below which infertile males were likely to benefit from AOA were 71% for the proportion of sperm expressing PLCζ and 15.57 arbitrary units for mean PLCζ level.
Conclusion(s): PLCζ analysis is a useful diagnostic tool to determine patient eligibility for subsequent AOA treatment.
Mehdinejadiani S, Goudarzi N, Masjedi F, Govahi A, Mirani M, Mehdinejadiani K Reprod Sci. 2024; 31(10):2916-2942.
PMID: 39168919 DOI: 10.1007/s43032-024-01671-z.
Phospholipase C zeta: a hidden face of sperm for oocyte activation and early embryonic development.
Azil S, Mbaye M, Louanjli N, Ghazi B, Benkhalifa M Obstet Gynecol Sci. 2024; 67(5):467-480.
PMID: 39086217 PMC: 11424188. DOI: 10.5468/ogs.24019.
Molecular Mechanism of Oocyte Activation in Mammals: Past, Present, and Future Directions.
Sugita H, Takarabe S, Kageyama A, Kawata Y, Ito J Biomolecules. 2024; 14(3).
PMID: 38540777 PMC: 10968515. DOI: 10.3390/biom14030359.
Novel PLCZ1 mutation caused polyspermy during in vitro fertilization.
Tong K, Liu W, Sun L, Liu D, Xiang Y, Li C Asian J Androl. 2024; 26(4):389-395.
PMID: 38445955 PMC: 11280200. DOI: 10.4103/aja202376.
Parrella A, Medrano L, Aizpurua J, Gomez-Torres M Int J Mol Sci. 2024; 25(2).
PMID: 38279344 PMC: 10815952. DOI: 10.3390/ijms25021344.